- Home
- PLX vs BRIA Comparison
PLX vs BRIA Comparison
Compare PLX & BRIA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PLX
- BRIA
- Stock Information
- Founded
- PLX 1993
- BRIA 2011
- Country
- PLX Israel
- BRIA Singapore
- Employees
- PLX N/A
- BRIA N/A
- Industry
- PLX Biotechnology: Biological Products (No Diagnostic Substances)
- BRIA
- Sector
- PLX Health Care
- BRIA
- Exchange
- PLX Nasdaq
- BRIA NYSE
- Market Cap
- PLX 132.5M
- BRIA 120.4M
- IPO Year
- PLX 1998
- BRIA 2024
- Fundamental
- Price
- PLX $1.76
- BRIA $4.01
- Analyst Decision
- PLX
- BRIA
- Analyst Count
- PLX 0
- BRIA 0
- Target Price
- PLX N/A
- BRIA N/A
- AVG Volume (30 Days)
- PLX 382.4K
- BRIA 66.5K
- Earning Date
- PLX 11-14-2024
- BRIA 02-15-2025
- Dividend Yield
- PLX N/A
- BRIA N/A
- EPS Growth
- PLX N/A
- BRIA N/A
- EPS
- PLX N/A
- BRIA 92.24
- Revenue
- PLX $45,667,000.00
- BRIA $55,755,669.00
- Revenue This Year
- PLX N/A
- BRIA N/A
- Revenue Next Year
- PLX $88.94
- BRIA N/A
- P/E Ratio
- PLX N/A
- BRIA $0.04
- Revenue Growth
- PLX N/A
- BRIA 8.03
- 52 Week Low
- PLX $0.82
- BRIA $3.21
- 52 Week High
- PLX $1.90
- BRIA $4.34
- Technical
- Relative Strength Index (RSI)
- PLX 62.98
- BRIA N/A
- Support Level
- PLX $1.60
- BRIA N/A
- Resistance Level
- PLX $1.83
- BRIA N/A
- Average True Range (ATR)
- PLX 0.08
- BRIA 0.00
- MACD
- PLX -0.02
- BRIA 0.00
- Stochastic Oscillator
- PLX 71.15
- BRIA 0.00
About PLX Protalix BioTherapeutics Inc. (DE)
Protalix BioTherapeutics Inc is a biopharmaceutical company focused on the development and commercialization of recombinant therapeutic proteins based on its proprietary ProCellEx protein expression system or ProCellEx. It has developed taliglucerase alfa for the treatment of Gaucher disease. The company's products also treat diseases like Fabry disease and cystic fibrosis. The company's primary sources of revenue include its sales of BioManguinhos alfataliglicerase in Brazil and of drug substances to Pfizer under its Amended Pfizer Agreement. The company's pipeline consists of ELFABRIO, Uricase, and Long Acting DNase I.
About BRIA BRILLIA INC
BrilliA Inc is engaged in business of sales and marketing of lingerie's products including bra, panty and body suit, mainly serving the American, European and other markets.